Hazard Information | Back Directory | [Uses]
Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used for the synthesis of antibody-drug conjugate BAY 1129980[1]. | [References]
[1] Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May;16(5):893-904. DOI:10.1158/1535-7163.MCT-16-0474 |
|
Company Name: |
Biolab Reagents
|
Tel: |
027-65279366 18108604356 |
Website: |
www.biolabreagent.com/ |
|